Critical role of zinc as either an antioxidant or a prooxidant in cellular systems

Oxidative Medicine and Cellular Longevity

Volumn 2018, Issue , 2018, Pages

  Lee, Sung Ryul ^a  

^a Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ZINC; ANTIOXIDANT; CHELATING AGENT;

ANTIOXIDANT ACTIVITY; HOMEOSTASIS AND REGULATION; MITOCHONDRION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; REVIEW; ZINC DEFICIENCY; ANIMAL; HOMEOSTASIS; HUMAN; INFLAMMATION; METABOLISM; NERVE CELL; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; CHELATING AGENTS; HOMEOSTASIS; HUMANS; INFLAMMATION; MITOCHONDRIA; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; ZINC;

EID: 85053842139     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2018/9156285     Document Type: Review

References (137)

1. H. Sies, “Oxidative stress: from basic research to clinical application,” The American Journal of Medicine, vol. 91, no. 3, Supplement 3, pp. S31-S38, 1991.
2. A. M. Pisoschi and A. Pop, “The role of antioxidants in the chemistry of oxidative stress: a review,” European Journal of Medicinal Chemistry, vol. 97, pp. 55-74, 2015.
3. B. Poljsak, D. Suput, and I. Milisav, “Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 956792, 11 pages, 2013.
4. P. I. Oteiza, G. G. Mackenzie, and S. V. Verstraeten, “Metals in neurodegeneration: involvement of oxidants and oxidant-sensitive transcription factors,” Molecular Aspects of Medicine, vol. 25, no. 1-2, pp. 103-115, 2004.
5. I. Korovila, M. Hugo, J. P. Castro et al., “Proteostasis, oxidative stress and aging,” Redox Biology, vol. 13, pp. 550-567, 2017.
6. S. J. S. Flora, “Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 4, pp. 191-206, 2009.
7. K. Jomova and M. Valko, “Advances in metal-induced oxidative stress and human disease,” Toxicology, vol. 283, no. 2-3, pp. 65-87, 2011.
8. P. Poprac, K. Jomova, M. Simunkova, V. Kollar, C. J. Rhodes, and M. Valko, “Targeting free radicals in oxidative stress-related human diseases,” Trends in Pharmacological Sciences, vol. 38, no. 7, pp. 592-607, 2017.
9. M. Valko, K. Jomova, C. J. Rhodes, K. Kuča, and K. Musílek, “Redox- and non-redox-metal-induced formation of free radicals and their role in human disease,” Archives of Toxicology, vol. 90, no. 1, pp. 1-37, 2016.
10. C. W. Siah, D. Trinder, and J. K. Olynyk, “Iron overload,” Clinica Chimica Acta, vol. 358, no. 1-2, pp. 24-36, 2005.
11. E. Mocchegiani, L. Costarelli, R. Giacconi, F. Piacenza, A. Basso, and M. Malavolta, “Zinc, metallothioneins and immunosenescence: effect of zinc supply as nutrigenomic approach,” Biogerontology, vol. 12, no. 5, pp. 455-465, 2011.
12. S. Clemens and J. F. Ma, “Toxic heavy metal and metalloid accumulation in crop plants and foods,” Annual Review of Plant Biology, vol. 67, no. 1, pp. 489-512, 2016.
13. A. C. Tolcin, 2009 Minerals Yearbook, United States Geological Survey, Washington, DC, USA, 2011.
14. J. E. Cummings and J. P. Kovacic, “The ubiquitous role of zinc in health and disease,” Journal of Veterinary Emergency and Critical Care, vol. 19, no. 3, pp. 215-240, 2009.
15. K. Jurowski, B. Szewczyk, G. Nowak, and W. Piekoszewski, “Biological consequences of zinc deficiency in the pathome-chanisms of selected diseases,” JBIC Journal of Biological Inorganic Chemistry, vol. 19, no. 7, pp. 1069-1079, 2014.
16. A. S. Prasad, “Essentiality and toxicity of zinc,” Scandinavian Journal of Work, Environment & Health, vol. 19, Supplement 1, pp. 134-136, 1993.
17. H. N. Hoffman II, R. L. Phyliky, and C. R. Fleming, “Zinc-induced copper deficiency,” Gastroenterology, vol. 94, no. 2, pp. 508-512, 1988.
18. S. R. Simon, R. F. Branda, B. H. Tindle, and S. L. Burns, “Copper deficiency and sideroblastic anemia associated with zinc ingestion,” American Journal of Hematology, vol. 28, no. 3, pp. 181-183, 1988.
19. M. Yasuyuki, K. Kunihiro, S. Kurissery, N. Kanavillil, Y. Sato, and Y. Kikuchi, “Antibacterial properties of nine pure metals: a laboratory study using Staphylococcus aureus and Escherichia coli,” Biofouling, vol. 26, no. 7, pp. 851-858, 2010.
20. A. B. G. Lansdown, U. Mirastschijski, N. Stubbs, E. Scanlon, and M. S. Ågren, “Zinc in wound healing: theoretical, experimental, and clinical aspects,” Wound Repair and Regeneration, vol. 15, no. 1, pp. 2-16, 2007.
21. K. L. Haas and K. J. Franz, “Application of metal coordination chemistry to explore and manipulate cell biology,” Chemical Reviews, vol. 109, no. 10, pp. 4921-4960, 2009.
22. T. Kochanczyk, A. Drozd, and A. Krezel, “Relationship between the architecture of zinc coordination and zinc binding affinity in proteins - insights into zinc regulation,” Metallomics, vol. 7, no. 2, pp. 244-257, 2015.
23. W. Maret, “Zinc biochemistry: from a single zinc enzyme to a key element of life,” Advances in Nutrition, vol. 4, no. 1, pp. 82-91, 2013.
24. T. Fukada and T. Kambe, Eds., Zinc Signals in Cellular Functions and Disorders, Springer, Tokyo, Japan, 2014.
25. L. C. Costello, C. C. Fenselau, and R. B. Franklin, “Evidence for operation of the direct zinc ligand exchange mechanism for trafficking, transport, and reactivity of zinc in mammalian cells,” Journal of Inorganic Biochemistry, vol. 105, no. 5, pp. 589-599, 2011.
26. T. M. Bray and W. J. Bettger, “The physiological role of zinc as an antioxidant,” Free Radical Biology & Medicine, vol. 8, no. 3, pp. 281-291, 1990.
27. M. Jarosz, M. Olbert, G. Wyszogrodzka, K. Młyniec, and T. Librowski, “Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling,” Inflammopharma-cology, vol. 25, no. 1, pp. 11-24, 2017.
28. N. Efeovbokhan, S. K. Bhattacharya, R. A. Ahokas et al., “Zinc and the prooxidant heart failure phenotype,” Journal of Cardiovascular Pharmacology, vol. 64, no. 4, pp. 393-400, 2014.
29. Y. Yuan, F. Niu, Y. Liu, and N. Lu, “Zinc and its effects on oxidative stress in Alzheimer's disease,” Neurological Sciences, vol. 35, no. 6, pp. 923-928, 2014.
30. 2+ loads in cortical neurons,” PLoS One, vol. 8, no. 12, article e83347, 2013.
31. Y. H. Kim, E. Y. Kim, B. J. Gwag, S. Sohn, and J. Y. Koh, “Zinc-induced cortical neuronal death with features of apoptosis and necrosis: mediation by free radicals,” Neuroscience, vol. 89, no. 1, pp. 175-182, 1999.
32. J. Y. Koh, S. W. Suh, B. J. Gwag, Y. Y. He, C. Y. Hsu, and D. W. Choi, “The role of zinc in selective neuronal death after transient global cerebral ischemia,” Science, vol. 272, no. 5264, pp. 1013-1016, 1996.
33. R. D. Palmiter, “The elusive function of metallothioneins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 15, pp. 8428-8430, 1998.
34. W. Maret, “The function of zinc metallothionein: a link between cellular zinc and redox state,” The Journal of Nutrition, vol. 130, no. 5, pp. 1455S-1458S, 2000.
35. W. Maret, “Metallothionein redox biology in the cytoprotec-tive and cytotoxic functions of zinc,” Experimental Gerontology, vol. 43, no. 5, pp. 363-369, 2008.
36. C. Andreini, L. Banci, I. Bertini, and A. Rosato, “Counting the zinc-proteins encoded in the human genome,” Journal of Proteome Research, vol. 5, no. 1, pp. 196-201, 2006.
37. C. Andreini and I. Bertini, “A bioinformatics view of zinc enzymes,” Journal of Inorganic Biochemistry, vol. 111, pp. 150-156, 2012.
38. C. Andreini, I. Bertini, and A. Rosato, “Metalloproteomes: a bioinformatic approach,” Accounts of Chemical Research, vol. 42, no. 10, pp. 1471-1479, 2009.
39. S. V. Verstraeten, L. V. Nogueira, S. Schreier, and P. I. Oteiza, “Effect of trivalent metal ions on phase separation and membrane lipid packing: role in lipid peroxidation,” Archives of Biochemistry and Biophysics, vol. 338, no. 1, pp. 121-127, 1997.
40. M. Chvapil, “New aspects in the biological role of zinc: a stabilizer of macromolecules and biological membranes,” Life Sciences, vol. 13, no. 8, pp. 1041-1049, 1973.
41. B. L. O'Dell, “Role of zinc in plasma membrane function,” The Journal of Nutrition, vol. 130, no. 5, pp. 1432S-1436S, 2000.
42. M. Stefanidou, C. Maravelias, A. Dona, and C. Spiliopoulou, “Zinc: a multipurpose trace element,” Archives of Toxicology, vol. 80, no. 1, pp. 1-9, 2006.
43. L. M. Plum, L. Rink, and H. Haase, “The essential toxin: impact of zinc on human health,” International Journal of Environmental Research and Public Health, vol. 7, no. 12, pp. 1342-1365, 2010.
44. J. J. Langham Brown, “Zinc fume fever,” The British Institute of Radiology, vol. 61, no. 724, pp. 327-329, 1988.
45. A. S. Prasad, G. J. Brewer, E. B. Schoomaker, and P. Rabbani, “Hypocupremia induced by zinc therapy in adults,” JAMA, vol. 240, no. 20, pp. 2166-2168, 1978.
46. J. P. Liuzzi and R. J. Cousins, “Mammalian zinc transporters,” Annual Review of Nutrition, vol. 24, no. 1, pp. 151-172, 2004.
47. D. J. Eide, “Zinc transporters and the cellular trafficking of zinc,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1763, no. 7, pp. 711-722, 2006.
48. T. Kimura and T. Kambe, “The functions of metallothionein and ZIP and ZnT transporters: an overview and perspective,” International Journal of Molecular Sciences, vol. 17, no. 12, p. 336, 2016.
49. A. Bouron and J. Oberwinkler, “Contribution of calcium-conducting channels to the transport of zinc ions,” Pflügers Archiv, vol. 466, no. 3, pp. 381-387, 2014.
50. 2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair,” The Journal of Biological Chemistry, vol. 285, no. 34, pp. 26097-26106, 2010.
51. T. Kimura, N. Itoh, and G. K. Andrews, “Mechanisms of heavy metal sensing by metal response element-binding transcription factor-1,” Journal of Health Science, vol. 55, no. 4, pp. 484-494, 2009.
52. I. Bremner and N. T. Davies, “The induction of metallothionein in rat liver by zinc injection and restriction of food intake,” Biochemical Journal, vol. 149, no. 3, pp. 733-738, 1975.
53. G. K. Andrews, “Cellular zinc sensors: MTF-1 regulation of gene expression,” Biometals, vol. 14, no. 3/4, pp. 223-237, 2001.
54. 2+-induced toxicity,” Journal of Cell Science, vol. 127, no. 14, pp. 3094-3103, 2014.
55. Q. Lu, H. Haragopal, K. G. Slepchenko, C. Stork, and Y. V. Li, “Intracellular zinc distribution in mitochondria, ER and the Golgi apparatus,” International Journal of Physiology, Pathophysiology and Pharmacology, vol. 8, no. 1, pp. 35-43, 2016.
56. 2+ homeostasis in neurons from experimental and modeling studies,” American Journal of Physiology-Cell Physiology, vol. 294, no. 3, pp. C726-C742, 2008.
57. D. Juárez-Rebollar, C. Rios, C. Nava-Ruíz, and M. Méndez-Armenta, “Metallothionein in brain disorders,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 5828056, 12 pages, 2017.
58. Z. Zhou and Y. J. Kang, “Immunocytochemical localization of metallothionein and its relation to doxorubicin toxicity in transgenic mouse heart,” The American Journal of Pathology, vol. 156, no. 5, pp. 1653-1662, 2000.
59. B. Ye, W. Maret, and B. L. Vallee, “Zinc metallothionein imported into liver mitochondria modulates respiration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 5, pp. 2317-2322, 2001.
60. S. R. Hennigar and S. L. Kelleher, “Zinc networks: the cell-specific compartmentalization of zinc for specialized functions,” Biological Chemistry, vol. 393, no. 7, pp. 565-578, 2012.
61. A. H. Robbins, D. McRee, M. Williamson et al., “Refined crystal structure of Cd, Zn metallothionein at 2.0Åresolu-tion,” Journal of Molecular Biology, vol. 221, no. 4, pp. 1269-1293, 1991.
62. A. Krezel and W. Maret, “Different redox states of metallothionein/thionein in biological tissue,” Biochemical Journal, vol. 402, no. 3, pp. 551-558, 2007.
63. W. Maret, “Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc,” Neurochemistry International, vol. 27, no. 1, pp. 111-117, 1995.
64. N. M. Giles, A. B. Watts, G. I. Giles, F. H. Fry, J. A. Littlechild, and C. Jacob, “Metal and redox modulation of cysteine protein function,” Chemistry & Biology, vol. 10, no. 8, pp. 677-693, 2003.
65. M. Sato and I. Bremner, “Oxygen free radicals and metallothionein,” Free Radical Biology & Medicine, vol. 14, no. 3, pp. 325-337, 1993.
66. P. J. Thornalley and M. Vasak, “Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals,” Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol. 827, no. 1, pp. 36-44, 1985.
67. M. Penkowa, “Metallothioneins are multipurpose neuropro-tectants during brain pathology,” The FEBS Journal, vol. 273, no. 9, pp. 1857-1870, 2006.
68. C. D. Klaassen, S. Choudhuri, J. M. McKim, L. D. Lehman-McKeeman, and W. C. Kershaw, “In vitro and in vivo studies on the degradation of metallothionein,” Environ Health Perspect, vol. 102, Supplement 3, pp. 141-146, 1994.
69. J. F. Turrens, “Mitochondrial formation of reactive oxygen species,” The Journal of Physiology, vol. 552, no. 2, pp. 335-344, 2003.
70. F. L. Muller, Y. Liu, and H. Van Remmen, “Complex III releases superoxide to both sides of the inner mitochondrial membrane,” The Journal of Biological Chemistry, vol. 279, no. 47, pp. 49064-49073, 2004.
71. C. W. Shuttleworth and J. H. Weiss, “Zinc: new clues to diverse roles in brain ischemia,” Trends in Pharmacological Sciences, vol. 32, no. 8, pp. 480-486, 2011.
72. Z. Xu and J. Zhou, “Zinc and myocardial ischemia/reperfusion injury,” Biometals, vol. 26, no. 6, pp. 863-878, 2013.
73. A. B. Taylor, B. S. Smith, S. Kitada et al., “Crystal structures of mitochondrial processing peptidase reveal the mode for specific cleavage of import signal sequences,” Structure, vol. 9, no. 7, pp. 615-625, 2001.
74. B. Morgan, S. K. Ang, G. Yan, and H. Lu, “Zinc can play chaperone-like and inhibitor roles during import of mitochondrial small Tim proteins,” The Journal of Biological Chemistry, vol. 284, no. 11, pp. 6818-6825, 2009.
75. C. D. Ellis, F. Wang, C. W. MacDiarmid, S. Clark, T. Lyons, and D. J. Eide, “Zinc and the Msc2 zinc transporter protein are required for endoplasmic reticulum function,” The Journal of Cell Biology, vol. 166, no. 3, pp. 325-335, 2004.
76. J. D. Malhotra, H. Miao, K. Zhang et al., “Antioxidants reduce endoplasmic reticulum stress and improve protein secretion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 47, pp. 18525-18530, 2008.
77. E. Napoli, C. Ross-Inta, S. Wong et al., “Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome,” Human Molecular Genetics, vol. 20, no. 15, pp. 3079-3092, 2011.
78. Q. Sun, W. Zhong, W. Zhang, and Z. Zhou, “Defect of mitochondrial respiratory chain is a mechanism of ROS overproduction in a rat model of alcoholic liver disease: role of zinc deficiency,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 310, no. 3, pp. G205-G214, 2016.
79. 2+, ions with glyceraldehyde-3-phosphate dehydrogenase from bovine heart and rabbit muscle,” The International Journal of Biochemistry, vol. 24, no. 9, pp. 1501-1505, 1992.
80. 2+ on muscle glycolysis and their reversal by histidine,” Journal of Nutritional Science and Vitaminology, vol. 26, no. 4, pp. 357-366, 1980.
81. 2+ on rabbit muscle pyruvate kinase and reactivation by histidine,” Journal of Nutritional Science and Vitaminology, vol. 27, no. 2, pp. 107-116, 1981.
82. + and inhibition of glycolysis,” The Journal of Neuroscience, vol. 20, no. 9, pp. 3139-3146, 2000.
83. K. E. Dineley, T. V. Votyakova, and I. J. Reynolds, “Zinc inhibition of cellular energy production: implications for mitochondria and neurodegeneration,” Journal of Neurochemistry, vol. 85, no. 3, pp. 563-570, 2003.
84. 2+ inhibits α-ketoglutarate-stimulated mitochondrial respiration and the isolated α-ketoglutarate dehydrogenase complex,” The Journal of Biological Chemistry, vol. 275, no. 18, pp. 13441-13447, 2000.
85. I. G. Gazaryan, B. F. Krasnikov, G. A. Ashby, R. N. F. Thorneley, B. S. Kristal, and A. M. Brown, “Zinc is a potent inhibitor of thiol oxidoreductase activity and stimulates reactive oxygen species production by lipoamide dehydrogenase,” The Journal of Biological Chemistry, vol. 277, no. 12, pp. 10064-10072, 2002.
86. 2+,” The Journal of Biological Chemistry, vol. 281, no. 46, pp. 34803-34809, 2006.
87. Y. Liu, D. S. Barber, P. Zhang, and B. Liu, “Complex II of the mitochondrial respiratory chain is the key mediator of divalent manganese-induced hydrogen peroxide production in microglia,” Toxicological Sciences, vol. 132, no. 2, pp. 298-306, 2013.
88. H. Nohl, L. Gille, A. Kozlov, and K. Staniek, “Are mitochondria a spontaneous and permanent source of reactive oxygen species?,” Redox Report, vol. 8, no. 3, pp. 135-141, 2003.
89. 1 complex by blocking a protonatable group,” The Journal of Biological Chemistry, vol. 270, no. 42, pp. 25001-25006, 1995.
90. S. S. Kuznetsova, N. V. Azarkina, T. V. Vygodina, S. A. Siletsky, and A. A. Konstantinov, “Zinc ions as cytochrome C oxidase inhibitors: two sites of action,” Biochemistry, vol. 70, no. 2, pp. 128-136, 2005.
91. 1,” Journal of Bioenergetics and Biomembranes, vol. 25, no. 3, pp. 297-306, 1993.
92. 2+-permeable AMPA/ kainate channels triggers prolonged mitochondrial superoxide production,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 5, pp. 2414-2419, 1999.
93. K. E. Dineley, L. L. Richards, T. V. Votyakova, and I. J. Reynolds, “Zinc causes loss of membrane potential and elevates reactive oxygen species in rat brain mitochondria,” Mitochondrion, vol. 5, no. 1, pp. 55-65, 2005.
94. i,” Neurobiology of Disease, vol. 7, no. 4, pp. 310-320, 2000.
95. V. Petronilli, P. Costantini, L. Scorrano, R. Colonna, S. Passamonti, and P. Bernardi, “The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents,” The Journal of Biological Chemistry, vol. 269, no. 24, pp. 16638-16642, 1994.
96. 2+ inhibits mitochondrial movement in neurons by phosphatidylinositol 3-kinase activation,” The Journal of Neuroscience, vol. 25, no. 41, pp. 9507-9514, 2005.
97. 2 in cultured hippocampal neurons,” The Journal of Neuroscience, vol. 28, no. 12, pp. 3114-3122, 2008.
98. J. M. Mates, C. Perez-Gomez, and I. Nunez de Castro, “Antioxidant enzymes and human diseases,” Clinical Biochemistry, vol. 32, no. 8, pp. 595-603, 1999.
99. B. Halliwell, “Antioxidants in human health and disease,” Annual Review of Nutrition, vol. 16, no. 1, pp. 33-50, 1996.
100. T. Goto, M. Komai, H. Suzuki, and Y. Furukawa, “Long-term zinc deficiency decreases taste sensitivity in rats,” The Journal of Nutrition, vol. 131, no. 2, pp. 305-310, 2001.
101. J. K. Chesters and M. Will, “Some factors controlling food intake by zinc-deficient rats,” The British Journal of Nutrition, vol. 30, no. 3, pp. 555-566, 1973.
102. C. G. Taylor, W. J. Bettger, and T. M. Bray, “Effect of dietary zinc or copper deficiency on the primary free radical defense system in rats,” The Journal of Nutrition, vol. 118, no. 5, pp. 613-621, 1988.
103. 2+-deficient or an active Cu,Zn-superoxide dismutase,” Aging Cell, vol. 4, no. 1, pp. 41-52, 2005.
104. J. C. Barbato, O. Catanescu, K. Murray, P. M. DiBello, and D. W. Jacobsen, “Targeting of metallothionein by L-homo-cysteine: a novel mechanism for disruption of zinc and redox homeostasis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 49-54, 2007.
105. K. Hegetschweiler, P. Saltman, C. Dalvit, and P. E. Wright, “Kinetics and mechanisms of the oxidation of myoglobin by Fe(III) and Cu(II) complexes,” Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol. 912, no. 3, pp. 384-397, 1987.
106. A. S. Prasad, “Zinc is an antioxidant and anti-inflammatory agent: its role in human health,” Frontiers in Nutrition, vol. 1, p. 14, 2014.
107. J. C. Ludwig, R. L. Misiorowski, M. Chvapil, and M. D. Seymour, “Interaction of zinc ions with electron carrying coenzymes NADPH and NADH,” Chemico-Biological Interactions, vol. 30, no. 1, pp. 25-34, 1980.
108. W. J. Bettger, T. J. Fish, and B. L. O'Dell, “Effects of copper and zinc status of rats on erythrocyte stability and superoxide dismutase activity,” Proceedings of the Society for Experimental Biology and Medicine, vol. 158, no. 2, pp. 279-282, 1978.
109. H. Pasantes-Morales and C. Cruz, “Protective effect of taurine and zinc on peroxidation-induced damage in photoreceptor outer segments,” Journal of Neuroscience Research, vol. 11, no. 3, pp. 303-311, 1984.
110. G. L. Floersheim, “Protection against acute ethanol toxicity in mice by zinc aspartate, glycols, levulose and pyritinol,” Agents and Actions, vol. 16, no. 6, pp. 580-584, 1985.
111. G. L. Floersheim and A. Bieri, “Further studies on selective radioprotection by organic zinc salts and synergism of zinc aspartate with WR 2721,” The British Journal of Radiology, vol. 63, no. 750, pp. 468-475, 1990.
112. P. K. Singal, K. S. Dhillon, R. E. Beamish, and N. S. Dhalla, “Protective effect of zinc against catecholamine-induced myocardial changes electrocardiographic and ultrastructural studies,” Laboratory Investigation, vol. 44, no. 5, pp. 426-433, 1981.
113. S. R. Powell, D. Hall, L. Aiuto, R. A. Wapnir, S. Teichberg, and A. J. Tortolani, “Zinc improves postischemic recovery of isolated rat hearts through inhibition of oxidative stress,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 266, no. 6, Part 2, pp. H2497-H2507, 1994.
114. S. R. Powell, R. L. Nelson, J. M. Finnerty et al., “Zinc-bis-histidinate preserves cardiac function in a porcine model of cardioplegic arrest,” The Annals of Thoracic Surgery, vol. 64, no. 1, pp. 73-80, 1997.
115. M. M. Cortese, C. V. Suschek, W. Wetzel, K. D. Kröncke, and V. Kolb-Bachofen, “Zinc protects endothelial cells from hydrogen peroxide via Nrf2-dependent stimulation of glutathione biosynthesis,” Free Radical Biology & Medicine, vol. 44, no. 12, pp. 2002-2012, 2008.
116. T. Fukada, S. Yamasaki, K. Nishida, M. Murakami, and T. Hirano, “Zinc homeostasis and signaling in health and diseases: zinc signaling,” JBIC Journal of Biological Inorganic Chemistry, vol. 16, no. 7, pp. 1123-1134, 2011.
117. G. Lyubartseva and M. A. Lovell, “A potential role for zinc alterations in the pathogenesis of Alzheimer's disease,” BioFactors, vol. 38, no. 2, pp. 98-106, 2012.
118. K. Smidt and J. Rungby, “ZnT3: a zinc transporter active in several organs,” Biometals, vol. 25, no. 1, pp. 1-8, 2012.
119. S.-J. Lee and J.-Y. Koh, “Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes,” Molecular Brain, vol. 3, no. 1, p. 30, 2010.
120. P. W. Land and E. Aizenman, “Zinc accumulation after target loss: an early event in retrograde degeneration of thalamic neurons,” The European Journal of Neuroscience, vol. 21, no. 3, pp. 647-657, 2005.
121. + channels,” Neuron, vol. 41, no. 3, pp. 351-365, 2004.
122. C. Jacob, W. Maret, and B. L. Vallee, “Ebselen, a selenium-containing redox drug, releases zinc from metallothionein,” Biochemical and Biophysical Research Communications, vol. 248, no. 3, pp. 569-573, 1998.
123. A. T. Dinkova-Kostova, W. D. Holtzclaw, and N. Wakabayashi, “Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metal-loprotein,” Biochemistry, vol. 44, no. 18, pp. 6889-6899, 2005.
124. G. Salazar, J. Huang, R. G. Feresin, Y. Zhao, and K. K. Griendling, “Zinc regulates Nox1 expression through a NF-κB and mitochondrial ROS dependent mechanism to induce senescence of vascular smooth muscle cells,” Free Radical Biology & Medicine, vol. 108, pp. 225-235, 2017.
125. M. Malavolta, L. Costarelli, R. Giacconi et al., “Changes in Zn homeostasis during long term culture of primary endothelial cells and effects of Zn on endothelial cell senescence,” Experimental Gerontology, vol. 99, pp. 35-45, 2017.
126. A. Q. Truong-Tran, L. H. Ho, F. Chai, and P. D. Zalewski, “Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death,” The Journal of Nutrition, vol. 130, no. 5, pp. 1459S-1466S, 2000.
127. B. Hennig, P. Meerarani, P. Ramadass et al., “Zinc nutrition and apoptosis of vascular endothelial cells: implications in atherosclerosis,” Nutrition, vol. 15, no. 10, pp. 744-748, 1999.
128. D. K. Perry, M. J. Smyth, H. R. Stennicke et al., “Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis,” The Journal of Biological Chemistry, vol. 272, no. 30, pp. 18530-18533, 1997.
129. R. B. Franklin and L. C. Costello, “The important role of the apoptotic effects of zinc in the development of cancers,” Journal of Cellular Biochemistry, vol. 106, no. 5, pp. 750-757, 2009.
130. K. M. Noh and J. Y. Koh, “Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes,” The Journal of Neuroscience, vol. 20, article Rc111, 2000.
131. M. D. Pluth, E. Tomat, and S. J. Lippard, “Biochemistry of mobile zinc and nitric oxide revealed by fluorescent sensors,” Annual Review of Biochemistry, vol. 80, no. 1, pp. 333-355, 2011.
132. M. A. Aras, H. Hara, K. A. Hartnett, K. Kandler, and E. Aizenman, “Protein kinase C regulation of neuronal zinc signaling mediates survival during preconditioning,” Journal of Neurochemistry, vol. 110, no. 1, pp. 106-117, 2009.
133. H. Haase and W. Maret, “Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/ insulin-like growth factor-1 signaling,” Experimental Cell Research, vol. 291, no. 2, pp. 289-298, 2003.
134. D. Ciubotariu, C. M. Ghiciuc, and C. E. Lupusoru, “Zinc involvement in opioid addiction and analgesia - should zinc supplementation be recommended for opioid-treated persons?,” Substance Abuse Treatment, Prevention, and Policy, vol. 10, no. 1, p. 29, 2015.
135. S. R. Lee, S. J. Noh, J. R. Pronto et al., “The critical roles of zinc: beyond impact on myocardial signaling,” The Korean Journal of Physiology & Pharmacology, vol. 19, no. 5, pp. 389-399, 2015.
136. S. Noh, S. R. Lee, Y. J. Jeong et al., “The direct modulatory activity of zinc toward ion channels,” Integrative Medicine Research, vol. 4, no. 3, pp. 142-146, 2015.
137. W. Q. Ding and S. E. Lind, “Metal ionophores - an emerging class of anticancer drugs,” IUBMB Life, vol. 61, no. 11, pp. 1013-1018, 2009.